Pharmaceuticals and Biotechnology Stocks Scatter Chart

103 companies Industry group in Healthcare P/E vs Revenue Growth (1y) (TTM)
Universe
Plot any two of 343 metrics The preset pairs are free. Subscribers can put any metric on either axis.
Highlight

P/E vs Revenue Growth (1y) (TTM)

Company Outlier, pinned to the edge Highlighted Trend

Each dot is one of the 103 Pharmaceuticals and Biotechnology stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 16.3% and the median P/E 17.14. Pinned to the edge: 10 outliers on X and 4 on Y.

Rank correlation 0.01 Trend R² 0.04 X middle half 5.4% to 43.4% Y middle half 6.79 to 40.49
24High Revenue Growth (1y) (TTM), high P/E
28Low Revenue Growth (1y) (TTM), high P/E
23Low Revenue Growth (1y) (TTM), low P/E
28High Revenue Growth (1y) (TTM), low P/E

Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.

Companies

103 plotted
# Industry
1 LLYEli Lilly 45.5% 46.74 $1.36T Pharmaceuticals
2 JNJJohnson & Johnson 7.8% 42.83 $688.76B Pharmaceuticals
3 ABBVAbbVie 10.7% 50.48 $521.69B Pharmaceuticals
4 MRKMerck 4.9% 148.68OUT $364.31B Pharmaceuticals
5 AZNAstrazeneca 7.8% 25.92 $285.96B Pharmaceuticals
6 AMGNAmgen 8.2% 26.83 $251.88B Biotechnology
7 ABTAbbott Laboratories 10.0% 40.05 $187.98B Medical Devices
8 PFEPfizer 1.3% 40.85 $164.73B Pharmaceuticals
9 VRTXVertex Pharmaceuticals 10.5% 34.34 $136.55B Biotechnology
10 BMYBristol Myers Squibb 4.2% 14.02 $129.66B Pharmaceuticals
11 GSKGsk 82.9% 8.11 $108.86B Pharmaceuticals
12 REGNRegeneron Pharmaceuticals 18.6% 20.17 $97.17B Biotechnology
13 CORCencora 5.0% 22.64 $68.51B Drug Distribution
14 ARGXArgenx Se 61.5% 31.35 $59.41B Biotechnology
15 SNYSanofi -19.6% 6.24 $58.98B Pharmaceuticals
16 IDXXIdexx Laboratories 11.9% 46.96 $55.49B Animal Health
17 TEVATeva Pharmaceutical Industries 2.7% 102.64 $51.97B Generic Drugs
18 ONCBeOne Medicines 32.9% 51.73 $47.53B Pharmaceuticals
19 GEHCGE HealthCare Technologies 6.9% 17.42 $37.54B Diagnostic Equipment
20 BIIBBiogen 2.3% 107.78 $37.46B Biotechnology
21 ALCAlcon 8.0% 54.90 $36.13B Medical Devices
22 ZTSZoetis 0.9% 13.76 $34.16B Animal Health
23 UTHRUnited Therapeutics 1.9% 20.51 $25.06B Pharmaceuticals
24 ALNYAlnylam Pharmaceuticals 60.8% 8.34 $22.09B Biotechnology
25 ZBHZimmer Biomet Holdings 7.0% 25.63 $19.53B Medical Devices
26 ASNDAscendis Pharma A 93.8% 16.31 $17.07B Biotechnology
27 NBIXNeurocrine Biosciences 38.0% 24.21 $16.96B Pharmaceuticals
28 EXELExelixis 9.1% 19.24 $16.88B Pharmaceuticals
29 KNSAKiniksa Pharmaceuticals International 58.2% 68.75 $15.13B Biotechnology
30 RDYDr Reddys Laboratories -10.5% 33.78 $12.31B Generic Drugs
31 HALOHalozyme Therapeutics 45.0% 23.51 $11.42B Biotechnology
32 BWXTBWX Technologies 17.7% 30.09 $11.27B Nuclear Equipment
33 TGTXTg Therapeutics 68.8% 85.63 $9.75B Biotechnology
34 GMEDGlobus Medical 13.4% 17.35 $9.56B Medical Devices
35 KRYSKrystal Biotech 26.0% 40.14 $9.04B Gene and Cell Therapy
36 CHWYChewy 5.9% 33.42 $9.04B Packaged Foods
37 PTGXProtagonist Therapeutics 163.7%OUT 25.39 $8.54B Biotechnology
38 CORTCorcept Therapeutics 30.0% 48.81 $7.98B Pharmaceuticals
39 AMRXAmneal Pharmaceuticals 8.9% 53.85 $7.45B Generic Drugs
40 LGNDLigand Pharmaceuticals 1.0% 119.78 $6.18B Biotechnology
41 FMSFresenius Medical Care AG -49.1% 6.71 $6.16B Healthcare Services
42 EWTXEdgewise Therapeutics 36.6% 4.95 $5.03B Pharmaceuticals
43 OGNOrganon -3.2% 17.14 $3.65B Pharmaceuticals
44 ARQTArcutis Biotherapeutics 60.0% 123.78 $3.56B Biotechnology
45 SUPNSupernus 16.3% 7.79 $3.51B Pharmaceuticals
46 TAKTakeda Pharmaceutical -35.4% 10.69 $3.41B Pharmaceuticals
47 GMABGenmab A 22.5% 3.81 $3.30B Biotechnology
48 ACADAcadia Pharmaceuticals 14.8% 8.93 $3.24B Pharmaceuticals
49 ADMAAdma Biologics 6.3% 16.78 $3.05B Biotechnology
50 VCELVericel 25.3% 87.53 $2.91B Gene and Cell Therapy
51 LKFTLakefront Biotherapeutics 240.8%OUT 2.40 $2.24B Biotechnology
52 AUPHAurinia Pharmaceuticals 21.0% 6.68 $2.11B Pharmaceuticals
53 HRMYHarmony Biosciences Holdings 19.8% 11.04 $1.98B Pharmaceuticals
54 ZYMEZymeworks 97.8% 43.39 $1.87B Biotechnology
55 ETONEton Pharmaceuticals 100.6% 36.75 $1.84B Pharmaceuticals
56 ANIPAni Pharmaceuticals 25.9% 12.97 $1.71B Generic Drugs
57 NRIXNurix Therapeutics 738.8%OUT 5.86 $1.69B Biotechnology
58 PGENPrecigen 2,388%OUT 66.64 $1.63B Gene and Cell Therapy
59 JAZZJazz Pharmaceuticals 13.5% 7.59 $1.55B Pharmaceuticals
60 PAHCPhibro Animal Health 10.1% 14.21 $1.46B Animal Health
61 PCRXPacira BioSciences 3.7% 38.52 $1.45B Pharmaceuticals
62 ANABAnaptysbio 41.9% 87.82 $1.38B Biotechnology
63 INVAInnoviva 12.8% 7.09 $1.36B Pharmaceuticals
64 AMPHAmphastar Pharmaceuticals 3.1% 12.64 $1.25B Generic Drugs
65 MGTXMeiraGTx Holdings 1,366%OUT 11.36 $896.15M Gene and Cell Therapy
66 PHARPharming -6.5% 35.82 $884.12M Biotechnology
67 RIGLRigel Pharmaceuticals 2.2% 2.71 $837.18M Biotechnology
68 ABUSArbutus Biopharma 1,143%OUT 3.70 $812.59M Biotechnology
69 IRWDIronwood Pharmaceuticals 18.1% 5.32 $799.61M Biotechnology
70 COLLCollegium Pharmaceutical 7.7% 21.05 $786.73M Pharmaceuticals
71 DCTHDelcath Systems 38.1% 111.41 $714.55M Medical Devices
72 ZVRAZevra Therapeutics 75.2% 6.91 $539.71M Pharmaceuticals
73 KMDAKamada 12.6% 19.04 $466.68M Biotechnology
74 AGENAgenus 25.4% 14.31 $421.62M Biotechnology
75 FENCFennec Pharmaceuticals 71.1% 201.28OUT $409.20M Generic Drugs
76 PBYIPuma Biotechnology 9.4% 16.86 $401.70M Biotechnology
77 CRMDCorMedix 92.5% 5.90 $370.36M Pharmaceuticals
78 ELTPElite Pharmaceuticals 17.8% 5.90 $355.46M Generic Drugs
79 ALECAlector 151.2% 6.86 $285.18M Biotechnology
80 QTTBQ32 Bio 75.7% 120.37 $260.36M Biotechnology
81 INCYIncyte 24.9% 0.61 $246.78M Pharmaceuticals
82 PLXProtalix BioTherapeutics 37.0% 11.87 $245.74M Biotechnology
83 OMEROmeros 1,532%OUT 2.25 $236.99M Biotechnology
84 CGENCompugen 1,000.0%OUT 5.39 $198.56M Biotechnology
85 SIGASiga Technologies -69.6% 13.22 $196.88M Pharmaceuticals
86 FHTXFoghorn Therapeutics 357.3%OUT 15.73 $124.12M Biotechnology
87 ICCCImmucell 19.6% 51.96 $97.73M Animal Health
88 CPIXCumberland Pharmaceuticals 10.7% 1.28 $88.16M Pharmaceuticals
89 VXRTVaxart 22.3% 3.01 $87.73M Biotechnology
90 RLYBRallybio -35.6% 3.35 $83.84M Biotechnology
91 FBIOFortress Biotech 12.3% 0.65 $62.62M Biotechnology
92 ATNMActinium Pharmaceuticals 936.3%OUT 4.55 $51.56M Biotechnology
93 IBOImpact Biomedical 22.6% 27.21 $43.92M Biotechnology
94 UGUnited Guardian 23.6% 12.43 $38.87M Pharmaceuticals
95 ETSTEarth Science Tech 1.1% 6.89 $25.78M Generic Drugs
96 TXMDTherapeuticsMD 33.9% 177.40OUT $21.64M Pharmaceuticals
97 CSCIFCOSCIENS Biopharma -11.6% 4.52 $18.43M Specialty Chemicals
98 PLURPluri 10.0% 0.00 $15.09M Gene and Cell Therapy
99 KYNBKyntra Bio 3.0% 0.08 $13.93M Biotechnology
100 INNPFInnocan Pharma -9.6% 481.28OUT $5.78M Pharmaceuticals

Frequently Asked Questions

Which Pharmaceuticals and Biotechnology stocks look cheap relative to their growth?

Among Pharmaceuticals and Biotechnology stocks, the largest companies growing revenue faster than the median (16.3%) while trading below the median P/E (17.14) are Gsk (GSK), Alnylam Pharmaceuticals (ALNY), Ascendis Pharma A (ASND), Edgewise Therapeutics (EWTX) and Supernus (SUPN). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.

Which Pharmaceuticals and Biotechnology stocks are expensive for their growth?

The largest companies with a P/E above the median and revenue growth below it are Johnson & Johnson (JNJ), AbbVie (ABBV), Merck (MRK), Astrazeneca (AZN) and Amgen (AMGN).

What is the median P/E of Pharmaceuticals and Biotechnology stocks?

The median P/E across the 103 Pharmaceuticals and Biotechnology stocks plotted is 17.14, with the middle half between 6.79 and 40.49.

What is the median Revenue Growth (1y) (TTM) of Pharmaceuticals and Biotechnology stocks?

The median is 16.3%, with the middle half between 5.4% and 43.4%.

Is there a relationship between Revenue Growth (1y) (TTM) and P/E for Pharmaceuticals and Biotechnology stocks?

The rank correlation (Spearman) is 0.01, a no meaningful positive relationship: knowing one tells you little about the other.

How does this chart handle outliers?

A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 10 companies are outliers on Revenue Growth (1y) (TTM) and 4 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.

Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this industry group is included unless you choose primary industry only. Nothing on this page is investment advice.